Lindy G. Durrant

Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis

Nicholas FS Watson, Judith M. Ramage, Zahra Madjd et al. · International Journal of Cancer · 2005 · 249 citations

Life Sciences, Immunology, Oncology +17

Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

Ekaterina S. Jordanova, Arko Gorter, Ouissam Ayachi et al. · Clinical Cancer Research · 2008 · 236 citations · Full text

Life Sciences, Immunology, Oncology +17

NKG2D Ligand Expression in Human Colorectal Cancer Reveals Associations with Prognosis and Evidence for Immunoediting

Roger McGilvray, Robert A. Eagle, Nicholas FS Watson et al. · Clinical Cancer Research · 2009 · 191 citations · Full text

Medicine, Immunology, Oncology +17

Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer

Ahmad Al‐Attar, Nicholas FS Watson, J H Scholefield et al. · Gut · 2010 · 174 citations

Medicine, Immunology, Oncology +17

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients

Nicholas FS Watson, Ian Spendlove, Zahra Madjd et al. · International Journal of Cancer · 2005 · 159 citations · Full text

Life Sciences, Immunology, Oncology +17